V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016061 | 260008127 | 1.8 | 109.8 | Disease modification (D) | 2014-02-02 | 2014-03-08 | BENDAMUSTINE + RITUXIMAB | null | null | 260025284 | BENDAMUSTINE + RITUXIMAB |
| 260016062 | 260017990 | 1.56 | 131.2 | Curative (C) | 2014-03-12 | 2014-04-01 | BEP 5 Day | N | N | 260025290 | BEP |
| 260016063 | 260008129 | 1.79 | 74.1 | Curative (C) | 2016-02-03 | 2016-03-01 | BEP 5 Day | 02 | N | 260025291 | BEP |
| 260016064 | 260008130 | 2 | 53 | Disease modification (D) | 2014-07-20 | 2014-09-04 | BENDAMUSTINE + RITUXIMAB | N | N | 260025302 | BENDAMUSTINE + RITUXIMAB |
| 260016065 | 260008133 | 1.58 | 75 | Disease modification (D) | 2017-09-09 | 2018-01-29 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025311 | BENDAMUSTINE + RITUXIMAB |
| 260016066 | 260008134 | 1.5 | 60 | Palliative (P) | null | 2017-07-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025314 | BENDAMUSTINE + RITUXIMAB |
| 260016067 | 260013820 | 1.57 | 0 | Curative (C) | 2016-12-25 | 2017-01-08 | BEP 5 Day | N | N | 260025318 | BEP |
| 260016068 | 260008138 | null | 79.7 | null | null | 2015-12-21 | BEP 3 day | N | null | 260025324 | BEP |
| 260016069 | 260008138 | 1.7 | 70.1 | Palliative (P) | null | 2015-03-24 | BEP 3 day | N | N | 260025324 | BEP |
| 260016070 | 260016621 | null | 117 | Adjuvant (A) | 2014-11-06 | 2014-11-29 | BEP 3 day | null | N | 260025328 | BEP |
| 260016071 | 260008140 | 1.7 | 132 | Adjuvant (A) | 2014-06-27 | 2014-06-27 | BEP 3 day | 02 | N | 260025328 | BEP |
| 260016072 | 260013825 | 1.67 | 65.8 | Palliative (P) | 2013-08-26 | 2013-08-30 | Bendamustine+Rituximab(Sub Courses) | null | N | 260025330 | BENDAMUSTINE + RITUXIMAB |
| 260016073 | 260013826 | 1.64 | 76 | Disease modification (D) | 2017-01-01 | 2017-01-30 | BENDAMUSTINE + RITUXIMAB | N | N | 260025335 | BENDAMUSTINE + RITUXIMAB |
| 260016074 | 260008145 | 1.84 | null | Curative (C) | 2017-08-09 | 2017-08-09 | BENDAMUSTINE + RITUXIMAB | null | N | 260025346 | BENDAMUSTINE + RITUXIMAB |
| 260016075 | 260013829 | null | null | Disease modification (D) | 2016-08-25 | 2016-10-21 | BEP 5 Day | N | N | 260025350 | BEP |
| 260016076 | 260008149 | 1.79 | null | Palliative (P) | 2014-03-09 | 2014-03-20 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025353 | BENDAMUSTINE + RITUXIMAB |
| 260016077 | 260008151 | 1.84 | 135 | Disease modification (D) | 2005-11-12 | 2016-03-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025353 | BENDAMUSTINE + RITUXIMAB |
| 260016078 | 260008152 | 1.6 | 115 | Curative (C) | 2015-05-13 | 2015-05-15 | BEP 5 Day | 2 | N | 260025355 | BEP |
| 260016079 | 260008154 | 1.87 | 62 | Palliative (P) | 2016-11-17 | 2017-01-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025357 | BENDAMUSTINE + RITUXIMAB |
| 260016080 | 260008156 | 1.69 | 68.4 | Curative (C) | 2013-12-20 | 2014-01-24 | BEP 5 Day | N | N | 260025364 | BEP |
| 260016081 | 260008157 | 1.62 | 102.1 | Adjuvant (A) | 2016-10-24 | 2016-11-15 | BEP 3 day | N | null | 260025365 | BEP |
| 260016082 | 260008157 | 1.9 | 69.4 | Curative (C) | 2017-04-04 | 2017-04-05 | BEP 5 Day | 02 | N | 260025365 | BEP |
| 260016083 | 260008158 | 1.76 | 96.6 | Curative (C) | 2018-01-13 | 2018-01-26 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025376 | BENDAMUSTINE + RITUXIMAB |
| 260016084 | 260008159 | null | null | Curative (C) | 2015-11-28 | 2016-02-04 | BENDAMUSTINE + RITUXIMAB | null | N | 260025379 | BENDAMUSTINE + RITUXIMAB |
| 260016085 | 260008160 | 1.87 | null | Curative (C) | 2018-08-06 | 2018-08-06 | BENDAMUSTINE + RITUXIMAB | null | null | 260025385 | BENDAMUSTINE + RITUXIMAB |
| 260016086 | 260019228 | 1.5 | 52.9 | Curative (C) | 2014-08-30 | 2014-11-01 | BENDAMUSTINE + RITUXIMAB | N | null | 260025396 | BENDAMUSTINE + RITUXIMAB |
| 260016087 | 260008162 | 1.71 | 103 | Curative (C) | 2017-10-19 | 2017-11-14 | Bendamustine+Rituximab (1st Course) | N | N | 260025399 | BENDAMUSTINE + RITUXIMAB |
| 260016088 | 260013843 | 1.74 | null | Not known (9) | 2017-10-05 | 2017-11-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260025401 | BENDAMUSTINE + RITUXIMAB |
| 260016089 | 260008164 | null | 81.9 | Curative (C) | 2017-04-14 | 2017-07-04 | BEP 3 day | null | null | 260025403 | BEP |
| 260016090 | 260008166 | null | null | Palliative (P) | 2017-11-30 | 2018-01-05 | BEP 5 Day | 02 | null | 260025413 | BEP |
| 260016091 | 260008173 | 1.6 | 71 | Palliative (P) | 2017-08-05 | 2017-12-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025418 | BENDAMUSTINE + RITUXIMAB |
| 260016092 | 260013852 | null | null | Adjuvant (A) | 2017-06-27 | 2017-06-30 | BENDAMUSTINE + RITUXIMAB | N | null | 260025427 | BENDAMUSTINE + RITUXIMAB |
| 260016093 | 260008177 | null | null | Curative (C) | 2013-06-13 | 2013-07-31 | BEP 5 Day | 02 | N | 260025436 | BEP |
| 260016094 | 260008180 | 1.63 | 95.3 | Curative (C) | 2015-04-19 | 2015-07-08 | BEP 5 Day | N | N | 260025442 | BEP |
| 260016095 | 260008183 | 1.85 | 90.1 | Adjuvant (A) | 2013-10-28 | 2013-12-23 | BEP 3 day | 02 | N | 260025449 | BEP |
| 260016096 | 260008185 | 1.68 | 82.7 | Curative (C) | 2015-12-10 | 2016-01-22 | BEP 5 Day | N | N | 260025452 | BEP |
| 260016097 | 260008187 | 1.56 | 80.1 | Curative (C) | 2017-09-11 | 2017-09-18 | BEP 5 Day | N | N | 260025454 | BEP |
| 260016098 | 260018002 | null | null | Curative (C) | null | 2014-08-31 | BEP 3 day | N | N | 260025457 | BEP |
| 260016099 | 260018002 | 1.78 | 79.05 | Curative (C) | 2014-12-07 | 2014-12-14 | BEP 3 day | N | N | 260025457 | BEP |
| 260016100 | 260008191 | 1.73 | 91 | Palliative (P) | 2014-10-03 | 2014-10-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260025474 | BENDAMUSTINE + RITUXIMAB |
| 260016101 | 260008192 | 1.68 | 87.9 | Adjuvant (A) | 2018-02-02 | 2018-02-02 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025475 | BENDAMUSTINE + RITUXIMAB |
| 260016102 | 260018003 | 1.67 | 91.7 | Disease modification (D) | 2016-05-27 | 2016-06-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025479 | BENDAMUSTINE + RITUXIMAB |
| 260016103 | 260016643 | 1.68 | 58.1 | Curative (C) | 2013-02-17 | 2013-04-18 | Bendamustine+Rituximab (1st Course) | 2 | N | 260025481 | BENDAMUSTINE + RITUXIMAB |
| 260016104 | 260008196 | 1.7 | null | null | 2018-01-27 | 2018-02-17 | BEP 5 Day | 02 | N | 260025483 | BEP |
| 260016105 | 260008198 | 1.6 | 61 | Curative (C) | 2015-09-09 | 2015-09-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025485 | BENDAMUSTINE + RITUXIMAB |
| 260016106 | 260018004 | 1.61 | 61.2 | Curative (C) | 2014-04-23 | 2014-05-19 | BEP 5 Day | N | N | 260025489 | BEP |
| 260016107 | 260008201 | 1.6 | 103 | null | 2017-11-29 | 2017-12-05 | BEP 3 day | N | N | 260025501 | BEP |
| 260016108 | 260018005 | null | null | null | 2013-08-18 | 2013-08-23 | BEP 5 Day | null | null | 260025506 | BEP |
| 260016109 | 260013873 | null | null | Curative (C) | 2017-07-28 | 2017-08-04 | BENDAMUSTINE + RITUXIMAB | N | null | 260025514 | BENDAMUSTINE + RITUXIMAB |
| 260016110 | 260008205 | 1.83 | 87.8 | Palliative (P) | 2018-06-08 | 2018-06-12 | BEP 5 Day | N | N | 260025520 | BEP |